At the JP Morgan Healthcare conference, Merck (MSD) indicated its eagerness to c...
The full potential of cell and gene therapies (CGTs) has not yet been discovered...
Cristália has signed an agreement to license exclusive rights to market Formosa ...
The US FDA has granted priority review to the sBLA for ENHERTU, a treatment deve...
Celltrion USA has filed a biologics licence application (BLA) with the US FDA fo...
The EMA CHMP has recommended marketing authorisation for Bristol Myers Squibb’s ...
UK monarch King Charles was discharged from hospital today following treatment f...
An eye-catching milestone in hand, Ascidian will begin the Phase I/II STELLAR st...
"Wouldn’t you be mad?": What drives Sholto David, the obscure scientist who foun...
Merck's CEO told Sen. Bernie Sanders he wouldn't testify in the Senate because h...
After Sen. Chuck Schumer raised concerns about Zyn nicotine pouches, conservativ...
Using digital twins, healthcare professionals can analyse real-time individual h...
CAR-T cell therapies can provide durable cancer remission, however, a recent FDA...
Atossa Therapeutics estimates a Q3 Phase II readout for Z-endoxifen, as it plans...
Regeneron and Sanofi’s blockbuster anti-inflammatory drug generated global sales...
Renalys plans to start a registrational trial for sparsentan as a treatment for ...
